Atlas de Protocolos de Estimulación:




  1. de la Llata, E. S., Sánchez, M. R. M., Rodríguez, J. P., Treviño, A., Almeida, M. L., Sepúlveda, J., & Ayup, S. H. Altas concentraciones de estradiol sérico en reproducción asistida. altas concentraciones
  2. Abdalla, H., & Thum, M. Y. (2004). An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Human Reproduction, 19(4), 893-898.An elevated basal FSH re¯ects a quantitative rather than
  3. Farquhar, C., Rishworth, J. R., Brown, J., Nelen, W. L., & Marjoribanks, J. (2013). Assisted reproductive technology: an overview of Cochrane Reviews. The Cochrane Library.Assisted reproductive technology an overview of Cochrane
  4. Choi, J., & Smitz, J. (2015). Luteinizing hormone and human chorionic gonadotropin: a review of their varied clinical applications in assisted reproductive technology. Expert Review of Endocrinology & Metabolism, 10(1), 87-100. Luteinizing hormone and human chorionic gonadotropin
  5. Varillas del Río C1, Blanco Pérez S1, Doval Conde JL1, Reb o redo García RL2. Clomiphene citrate, does it still have any indication in Assisted Reproduction after fourty years of use?. 25- nº 5 – Septiembre-Octubre 2008. Citrato de Clomifeno ¿sigue teniendo indicación en Reproducción
  6. Keye, W. R., Marrs, R. P., Check, J. H., Schnell, V., Surrey, M., Marshall, D. C., & EMBRACE Study Group. (2004). Evaluation of mixed protocols with bravelle®(human-derived FSH) and repronex®(hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. Fertility and sterility, 82(2), 348-357. EMBRACE II. Evaluation of mixed protocols
  7. Iams, J. D. (2014). Identification of candidates for progesterone: why, who, how, and when?. Obstetrics & Gynecology, 123(6), 1317-1326. Identification_of_Candidates_for_Progesterone_ 24
  8. Choi, J., & Smitz, J. (2013). Luteinizing hormone and human chorionic gonadotropin: distinguishing unique physiologic roles. Gynecological Endocrinology, 30(3), 174-181.Luteinizing hormone and human chorionic gonadotropin
  9. Macklon, N. S., & Fauser, B. C. J. M. (2009). Medical approaches to ovarian stimulation for infertility. Yen and Jaffe’s Reproductive Endocrinology.Medical Approaches to Ovarian
  10. Birkenfeld, A., Mor-Joseph, S., Ezra, J., Simon, A., & Navot, D. (1990). Preovulatory luteinization during induction of follicular maturation with menotrophin and menotrophin-clomiphene combination. Human Reproduction, 5(5), 561-564.Preovulatory luteinization during induction of follicular
  11. Mesen, T. B., & Young, S. L. (2015). Progesterone and the Luteal Phase: A Requisite to Reproduction. Obstetrics and Gynecology Clinics of North America. Progesterone and the Luteal Phase A Requisite to Reproduction
  12. Hernández, A. S., Santos, H. R., Galache, V. P., Flores, T. H., & González, S. Receptividad endometrial: calificación numérica para el pronóstico de éxito en programas de reproducción asistida.receptividad endometrial. calificación para el pronóstico en programas de reproducción asistida
  13. Platteau, P., Andersen, A. N., Balen, A., Devroey, P., Sørensen, P., Helmgaard, L., & Arce, J. C. (2006). Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Human Reproduction, 21(7), 1798-1804. Similar ovulation rates, but different follicular development
  14. Ferguson, J., Hockley, J., Tiplady, R., & Burns, C. (2013). Standardization of therapeutic, urinary gonadotrophins: An update on the use and availability of International Standards for Menotrophin. Biologicals, 41(6), 435-438. Standardization of therapeutic, urinary gonadotrophins An update on
  15. Practice Committee of the American Society for Reproductive Medicine. (2013). Use of clomiphene citrate in infertile women: a committee opinion. Fertility and Sterility, 100(2), 341-348. Use of clomiphene citrate in infertile